Tumor vaccination after allogeneic bone marrow cell reconstitution of the non-myeloablatively conditioned tumor-bearing murine host

M. Zöller

DOI: https://doi.org/10.1186/1475-2867-4-S1-S19

IF: 6.429

2004-07-01

Cancer Cell International

Abstract:

What problem does this paper attempt to address?

Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990-2019

Sara Momtazmanesh,Sahar Saeedi Moghaddam,Elaheh Malakan Rad,Sina Azadnajafabad,Narges Ebrahimi,Esmaeil Mohammadi,Mahtab Rouhifard,Negar Rezaei,Masoud Masinaei,Nazila Rezaei,Mohammad Keykhaei,Arya Aminorroaya,Azin Ghamari,Bagher Larijani,Farshad Farzadfar

DOI: https://doi.org/10.1093/eurjpc/zwab211

2022-05-27

Abstract:Aims: Endocarditis accounts for significant morbidity and mortality. Timely diagnosis and prompt treatment are of paramount importance for optimal patient outcome. However, only few studies have assessed quality of care (QoC) in endocarditis. We aimed to describe QoC and changes in epidemiological features of endocarditis from 1990 to 2019. Methods and results: Using primary indices of mortality, incidence, years of life lost, years lived with disability, and disability-adjusted life year, obtained from the Global Burden of Disease Study 2019, we calculated four secondary measures. Principal component analysis was performed to calculate QoC index (QCI), scored on a scale of 0-100 with higher values indicating better QoC, for different locations, age groups, and genders from 1990 to 2019. The all-ages incidence rate of endocarditis was estimated to increase significantly from 1990 to 2019, while mortality rate did not change. The age-standardized QCI was 73.6% globally, with higher values in high-income countries than in low-income countries. High-income North America (82.0%) and Asia Pacific (81.1%) had the highest QCI, whereas Eastern Europe (43.3%) had the lowest. Globally, the 30-49 and 95+ age groups had the highest (91.3%) and the lowest (71.7%) QCI, respectively. In most countries, particularly those with lower socio-demographic index, women had better QCI. Conclusion: This is the first global assessment of QCI, shedding light on the current trends and highlighting the necessity of improving the endocarditis QoC, mainly by timely case detection, adherence to antibiotic prophylaxis guidelines, utilizing targeted antibiotics and advanced treatments, in the African region and resolving gender inequality in selected countries.
Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019

Ali Ajam,Parnian Shobeiri,Mohammad Keykhaei,Sahar Saeedi Moghaddam,Sara Momtazmanesh,Masoud Masinaei,Zahra Esfahani,Negar Rezaei,Mohammadreza Naderian,Arya Aminorroaya,Mohammad-Mahdi Rashidi,Nazila Rezaei,Bagher Larijani,Elaheh Malakan Rad,Farshad Farzadfar

DOI: https://doi.org/10.1016/j.ijcard.2022.06.060

2022-09-15

Abstract:Background: Endocarditis is a potentially life-threatening infectious disease associated with significant morbidity and mortality and an escalating incidence in recent decades. In this study, as a part of the global burden of disease (GBD) 2019 study, we intend to report endocarditis burden in Iran at national and provincial levels from 1990 to 2019. Method: This study was conducted using GBD 2019 study data on endocarditis from 1990 to 2019. We gathered incidence, prevalence, disability-adjusted life years (DALYs), and mortality rates in Iran and its 31 provinces by sex and age groups as epidemiological indices for endocarditis burden. Further decomposition analysis was also performed to delineate the endocarditis new cases trend. Results: On the country scale, age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), age-standardized mortality rate (ASMR), and age-standardized DALYs rate were (16.5 (95% uncertainty interval 13.7 to 19.8), 3.4 (2.9 to 4.1), 0.6 (0.5 to 0.9), and 14.4 (12.0 to 21.1) in 2019, respectively. Decomposition analysis showed that only 59.2% of the overall new cases increase (114.1%) was caused by the incidence rate change. All estimated age-standardized rates were higher in men in 1990 and 2019 with a ratio of 1.1-1.5. Conclusion: The ASIR and ASPR of endocarditis increased, and the ASMR and age-standardized DALYs rate declined over the past 30 years in Iran, nearly all the provinces followed the same pattern with North Khorasan having the Highest ASIR, ASPR, ASMR, and DALYs rates in both years. High systolic blood pressure (SBP) had the greatest attributed burden among risk factors.
Steroid hormone regulation of the voltage‐gated, calcium‐activated potassium channel expression in developing muscular and neural systems

Sheldon L. Garrison,J. Witten

DOI: https://doi.org/10.1002/dneu.20830

2010-11-01

Developmental Neurobiology

Abstract:A precise organization of gene expression is required for developing neural and muscular systems. Steroid hormones can control the expression of genes that are critical for development. In this study we test the hypothesis that the steroid hormone ecdysone regulates gene expression of the voltage‐gated calcium‐activated potassium ion channel, Slowpoke or KCNMA1. Late in adult development of the tobacco hawkmoth Manduca sexta, slowpoke (msslo) levels increased contributing to the maturation of the dorsal longitudinal flight muscles (DLMs) and CNS. We show that critical components of ecdysteroid gene regulation were present during upreglation of msslo in late adult DLM and CNS development. Ecdysteroid receptor complex heterodimeric partner proteins, the ecdysteroid receptor (EcR) and ultraspiracle (USP), and the ecdysone‐induced early gene, msE75B, were expressed at key developmental time points, suggesting that ecdysteroids direct aspects of gene expression in the DLMs during these late developmental stages. We provide evidence that ecdysteroids suppress msslo transcription in the DLMs; when titers decline msslo transcript levels increase. These results are consistent with msslo being a downstream gene in an ecdysteroid‐mediated gene cascade during DLM development. We also show that the ecdysteroids regulate msslo transcript levels in the developing CNS. These results will contribute to our understanding of how the spatiotemporal regulation of slowpoke transcription contributes to tailoring cell excitability to the differing physiological and behavioral demands during development. © 2010 Wiley Periodicals, Inc. Develop Neurobiol 70: 884–896, 2010
Characteristics of Infective Endocarditis in a Tertiary Hospital in East China

Huimin Xu,Siyu Cai,Haibin Dai

DOI: https://doi.org/10.1371/journal.pone.0166764

IF: 3.7

2016-01-01

PLoS ONE

Abstract:The epidemiology, clinical presentation, and treatment of infective endocarditis (IE) has significantly changed over the past few years in developed countries. However, relevant data from developing countries are different and remain scarce. The objective of this study was to evaluate the clinical presentations, treatment and outcomes of IE patients in a tertiary hospital in East China over an 8-year period. This was a retrospective observational study of consecutive cases of definite or possible IE as per the modified Duke criteria between January 2008 and December 2015. A total of 135 definite and 39 probable IE cases were identified. The mean age was 47.8 ± 15.7 years, with a male preponderance (1.9: 1). Degenerative valve disease accounted for 30.5% cases of IE, followed by congenital heart disease (29.9%) and rheumatic heart disease (14.9%). Native cardiac valves were present in 93.7% of the IE patients. Echocardiography and blood culture were performed in all patients, of whom 55.2% were found to have large vegetations (≥10 mm) and the positive rate of blood culture was 60.3%. Streptococcus remained the chief causative agent that was identified in 61.9% of culture-positive patients. Glycopeptide antibacterials and cephalosporins were the most frequently used antimicrobial drugs for IE therapy. Seventy-six (43.7%) of the IE patients were surgically treated. The mortality rate during hospital stay was 10.9%. Our data reflected clinical and microbiological profile, and treatment of IE in a tertiary hospital located in the East China.
Trends in the incidence and mortality of infective endocarditis in high-income countries between 1990 and 2019

Matthew Hammond-Haley,Adam Hartley,Becker M Al-Khayatt,Augustin J Delago,Alireza Ghajar,Utkarsh Ojha,Dominic C Marshall,Justin D Salciccioli,Bernard D Prendergast,Joseph Shalhoub

DOI: https://doi.org/10.1016/j.ijcard.2022.09.061

2023-01-15

Abstract:Background: Infective endocarditis (IE) remains a life-threatening disease with high morbidity and mortality. Objectives: To describe temporal trends in IE incidence, mortality and survival over the last 30 years. Methods: Nineteen high-income countries (the 'EU 15+') were included. Age-standardised and sex-stratified incidence rates (ASIRs) and mortality rates (ASMRs) for IE were extracted from the Global Burden of Disease (GBD) database between 1990 and 2019, and mortality to incidence ratios (ASMIRs) were calculated. Trends were analysed using Joinpoint regression analysis. Results: ASIRs were higher in males than females and increased in both sexes in all countries between 1990 and 2019. A recent steep rise in ASIRs was noted in several countries including the UK, the USA and Germany. ASMRs increased for both sexes in all countries except Finland and Austria. The largest increase in ASMR was observed in females in Italy (+246%). ASMIRs were generally higher in females compared to males, with large increases in ASMIRs (indicating worsening survival) at the end of the 20th century, but more recent stabilisation or decline across the study cohort. Conclusions: While the incidence and mortality of IE have increased over the last 30 years, recent data suggest that these trends have plateaued or reversed in most countries studied. However, a recent surge in incidence in several countries (including the USA and UK) is of concern, while unfavourable outcomes in females also merit attention. More encouragingly, this analysis provides the first indication of improving IE survival at population level, supporting recent advances in diagnosis and treatment.
A clinical analysis of 51 cases of infective endocarditis

YE Xiang-fang,YAN Dong,HUANG Jian-rong

DOI: https://doi.org/10.13381/j.cnki.cjm.2011.05.024

2011-01-01

Abstract:Objective To analyze the clinical features of infective endocarditis(IE) and help in early diagnosis and treatment.Method A retrospective analysis was performed on the clinical profiles of 51 cases comfirmed as IE from 20009.1.1 to 2010.10.31.The clinical profiles included underlying cardiac diseases,blood culture results,echocardiographic manifestations as well as clinical outcomes.Result Of the 51 patients,14(27.45%) had no underlying cardiac diseases,exceeding those(23.50%) who had previous rheumatic valvular disease.The predominat causative organism was Staphylococci(46.88%,15/32) and the second most prevalent pathogen was Streptococcus(28.12%,9/32).Echocardiographic evaluation showed a high positive rate(80.39%).21 patients underwent surgical treatments.5 cases of death occurred in the 51 cases.Conclusion The clinical characteristics of IE has greatly changed.The management of IE requires multidisciplinary cooperation.Clinicians and surgeons shall cooperate to manage the disease.
Mortality patterns in older adults with infective endocarditis in the US: A retrospective analysis

Hamza Ashraf,Zain Ali Nadeem,Haider Ashfaq,Sophia Ahmed,Ali Ashraf,Abdulqadir J Nashwan,Abdulqadir J. Nashwan

DOI: https://doi.org/10.1016/j.cpcardiol.2024.102455

IF: 16.464

2024-04-01

Current Problems in Cardiology

Abstract:BACKGROUND: Infective Endocarditis (IE) has become a significant cause of morbidity and mortality over the last two decades. Despite management advancements, mortality trends in the USA's geriatric population are unexplored. The aim of this study was to assess the trends and regional differences in IE related mortality among geriatric patients in the USA.METHODS: We analyzed death certificates sourced from the CDC WONDER database spanning 1999 to 2020. The research targeted individuals aged 65 and older. Age-adjusted mortality rates (AAMRs) per 100,000 and annual percent change (APC), along with 95% CI, were calculated through joinpoint regression analysis.RESULTS: From 1999 to 2020, infective endocarditis caused 222,573 deaths, showing a declining trend (APC: -0.8361). Males had higher AAMR (26.8) than females (22.2). NH White had the highest AAMR (25.8), followed by NH American Indians or Alaska Natives (19.6). Geographically, the Midwest had the highest AAMR (27.4), followed by the Northeast (25.8). Rural areas consistently had higher AAMRs (26.6) than urban areas (23.6), while 80.16% of deaths occurring in urban settings. North Dakota, Nebraska, and Montana had the highest state AAMRs, approximately double than the states with the lowest mortality rates: Mississippi, Hawaii, California, and Massachusetts. Those aged 85 and above accounted for 42.9% of deaths.CONCLUSION: IE mortality exhibited a clear pattern: rising till 2004, declining from 2004 to 2018, and increasing again till 2020. Key risk factors were male gender, Midwest residence, NH White ethnicity, and age ≥85.Targeted interventions are essential to reduce IE mortality, especially among vulnerable older populations.

cardiac & cardiovascular systems
Clinical and Microbiological Characteristics of Infective Endocarditis at a Cardiac Center in Saudi Arabia

Mazin Barry,Syed Abdul Bari,Muhammad Yasin Akhtar,Faizah Al Nahdi,Richilda Erlandez,Abdullah Al Khushail,Yahya Al Hebaishi

DOI: https://doi.org/10.1007/s44197-021-00013-5

Abstract:Background: Infective endocarditis (IE) is a serious disease with complex pathology and significant mortality. Little information is known regarding clinical and microbiological characteristics in Saudi Arabia. This study surveyed these characteristics at a Cardiac Center in Riyadh, Saudi Arabia over a period of 5 years. Methods: This retrospective study was done on all infective endocarditis (IE) patients admitted to Prince Sultan Cardiac Center between January 1, 2015, and December 31, 2019. Clinical characteristics, microbiological results, management, and outcomes were assessed. Result: A total of 340 cases of infective endocarditis were identified over the study period. Most patients (64%) were 50 years old or above, and 67% were males. Fever was the most common clinical presentation, and a murmur was audible in a fifth of patients. Blood cultures were positive in 177 (52%) cases. The most common organisms were Staphylococcus aureus, coagulase negative Staphylococcus and viridans group Streptococcus. Most common microbiological organisms causing native valve endocarditis were viridans group Streptococcus (32%) followed by methicillin-susceptible Staphylococcus aureus (21%), and for prosthetic valve endocarditis they were coagulase negative Staphylococcus (32%) followed by methicillin-susceptible Staphylococcus aureus (23%), the most common causes of culture negative endocarditis were Q-fever and brucellosis. Predisposing cardiac conditions were present in 127 (37%) patients, most commonly rheumatic heart disease and congenital heart disease. Surgical intervention was done in 26% of cases, with an overall in-hospital mortality rate of 6.76%. Conclusion: We demonstrate the epidemiological, clinical, and microbiological profile of infective endocarditis in a tertiary care cardiac center in Saudi Arabia. It gives information concerning the prevalence of responsible organisms. This information will be helpful in assessing patients with suspected IE and in planning management of cases knowing the relative frequency of types of microorganisms encountered.
Infective endocarditis:a review of 28 cases

Yaojiang Xu,Lilin Liu,Zhihui Zhou,Fang Lyu,Yunsong Yu

DOI: https://doi.org/10.3760/cma.j.issn.1000-6680.2014.01.009

2014-01-01

Abstract:Objective To investigate the clinical features,diagnostic examinations,treatment and clinical outcomes of patients with definite infective endocarditis (IE).Methods This retrospective study included 28 adults with IE who were admitted to Sir Run Run Shaw Hospital from January 1,2009 to June 30,2011.All the IE cases met the modified Duke criteria and the data were reviewed on clinical presentations,microbiological profiles,echocardiographic findings,in-hospital course and clinical outcomes.Results The mean age was (50.9± 17.4) years with a male preponderance.All patients had native valve IE.Mitral valve prolapse was the most common underlying heart disease.Fever was presented as the primary manifestation.Blood culture results were positive only in 36.4％ of the 11 cases.Streptococcus viridans represented the leading causative agent.Echocardiography was positive in 96.4％ of the cases.46.4％ of the cases underwent surgery for IE.Eighteen cases had at least one major complication.The in hospital mortality was 3.6％.Conclusions Typical clinical presentations of IE are rare.Comparing with previous studies,there are no changing trends in the microbiology.Advanced antibiotics are overused during the treatment,which is awaiting improvements.
Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature

Aref A Bin Abdulhak,Larry M Baddour,Patricia J Erwin,Bruno Hoen,Vivian H Chu,George A Mensah,Imad M Tleyjeh

DOI: https://doi.org/10.1016/j.gheart.2014.01.002

Abstract:Infective endocarditis (IE) is a life-threatening disease associated with serious complications. The GBD 2010 (Global Burden of Disease, Injuries, and Risk Factors) study IE expert group conducted a systematic review of IE epidemiology literature to inform estimates of the burden on IE in 21 world regions in 1990 and 2010. The disease model of IE for the GBD 2010 study included IE death and 2 sequelae: stroke and valve surgery. Several medical and science databases were searched for IE epidemiology studies in GBD high-, low-, and middle-income regions published between 1980 and 2008. The epidemiologic parameters of interest were IE incidence, proportions of IE patients who developed stroke or underwent valve surgery, and case fatality. Literature searches yielded 1,975 unique papers, of which 115 published in 10 languages were included in the systematic review. Eligible studies were population-based (17%), multicenter hospital-based (11%), and single-center hospital-based studies (71%). Population-based studies were reported from only 6 world regions. Data were missing or sparse in many low- and middle-income regions. The crude incidence of IE ranged between 1.5 and 11.6 cases per 100,000 people and was reported from 10 countries. The overall mean proportion of IE patients that developed stroke was 0.158 ± 0.091, and the mean proportion of patients that underwent valve surgery was 0.324 ± 0.188. The mean case fatality risk was 0.211 ± 0.104. A systematic review for the GBD 2010 study provided IE epidemiology estimates for many world regions, but highlighted the lack of information about IE in low- and middle-income regions. More complete knowledge of the global burden of IE will require improved IE surveillance in all world regions.
Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019

Mohammad-Mahdi Rashidi,Sahar Saeedi Moghaddam,Sina Azadnajafabad,Esmaeil Mohammadi,Amirmohammad Khalaji,Mohammad-Reza Malekpour,Mohammad Keykhaei,Negar Rezaei,Zahra Esfahani,Nazila Rezaei,GBD 2019 NAME Kidney Dysfunction Risk Factor Collaborators,Ali H Mokdad,Christopher J L Murray,Mohsen Naghavi,Bagher Larijani,Farshad Farzadfar,Mohsen Abbasi-Kangevari,Zeinab Abbasi-Kangevari,Samar Abd ElHafeez,Sherief Abd-Elsalam,Meriem Abdoun,Eman Abu-Gharbieh,Aqeel Ahmad,Ayman Ahmed,Sayer Al-Azzam,Rajaa M Al-Raddadi,Ala'a B Al-Tammemi,Javad Aminian Dehkordi,Mehrdad Amir-Behghadami,Jalal Arabloo,Mohammad Athar,Seyyed Shamsadin Athari,Mahsa Babaei,Hassan Babamohamadi,Nayereh Baghcheghi,Sara Bagherieh,Hamid Reza Baradaran,Akshaya Srikanth Bhagavathula,Vijayalakshmi S Bhojaraja,Milad Bonakdar Hashemi,Luciana Aparecida Campos,Azizallah Dehghan,Muhammed Elhadi,Waseem El-Huneidi,Ali Fatehizadeh,Alireza Feizkhah,Fataneh Ghadirian,Ali Gholami,Samer Hamidi,Hadi Hassankhani,Mahsa Heidari-Foroozan,Kamran Hessami,Kamal Hezam,Mohammad-Salar Hosseini,Soodabeh Hoveidamanesh,Rana Irilouzadian,Haitham Jahrami,Tannaz Jamialahmadi,Sathish Kumar Jayapal,Reema A Karasneh,Moien A B Khan,Yusra H Khan,Moawiah Mohammad Khatatbeh,Farzad Kompani,Hamid Reza Koohestani,Mohammed Kuddus,Soleiman Mahjoub,Ata Mahmoodpoor,Elaheh Malakan Rad,Ahmad Azam Malik,Tauqeer Hussain Mallhi,Mohammadreza Mobayen,Faezeh Mohammadi,Syam Mohan,Sara Momtazmanesh,Zuhair S Natto,Seyed Aria Nejadghaderi,Hassan Okati-Aliabad,Sina Rashedi,Amirfarzan Rashidi,Mahsa Rashidi,Elrashdy Moustafa Mohamed Redwan,Aly M A Saad,Fatemeh Saheb Sharif-Askari,Amirhossein Sahebkar,Morteza Saki,Abdallah M Samy,Elaheh Shaker,Jeevan K Shetty,Seyed Afshin Shorofi,Mohammad Tabish,Amir Taherkhani,Muhammad Umair,Seyed Mohammad Vahabi,Fereshteh Yazdanpanah,Arzu Yigit,Mazyar Zahir,Moein Zangiabadian

DOI: https://doi.org/10.1093/ckj/sfad279

2023-11-17

Abstract:Background: The study aimed to estimate the attributable burden to kidney dysfunction as a metabolic risk factor in the North Africa and Middle East (NAME) region and its 21 countries in 1990-2019. Methods: The data used in this study were obtained from the Global Burden of Diseases (GBD) 2019 study, which provided estimated measures of deaths, disability-adjusted life years (DALYs), and other epidemiological indicators of burden. To provide a better insight into the differences in the level of social, cultural, and economic factors, the Socio-Demographic Index (SDI) was used. Results: In the NAME region in 2019, the number of deaths attributed to kidney dysfunction was 296 632 (95% uncertainty interval: 249 965-343 962), which was about 2.5 times higher than in the year 1990. Afghanistan, Egypt, and Saudi Arabia had the highest, and Kuwait, Turkey, and Iran (Islamic Republic of) had the lowest age-standardized rate of DALYs attributed to kidney dysfunction in the region in 2019. Kidney dysfunction was accounted as a risk factor for ischemic heart disease, chronic kidney disease, stroke, and peripheral artery disease with 150 471, 111 812, 34 068, and 281 attributable deaths, respectively, in 2019 in the region. In 2019, both low-SDI and high-SDI countries in the region experienced higher burdens associated with kidney dysfunction compared to other countries. Conclusions: Kidney dysfunction increases the risk of cardiovascular diseases burden and accounted for more deaths attributable to cardiovascular diseases than chronic kidney disease in the region in 2019. Hence, policymakers in the NAME region should prioritize kidney disease prevention and control, recognizing that neglecting its impact on other diseases is a key limitation in its management.
Trends in infective endocarditis mortality in the United Kingdom and EU 15+ countries between 1990–2019: an analysis of the Global Burden of Diseases database

M Hammond-Haley,A Hartley,A J Delago,R Goodall,D Marshall,J D Salciccioli,J Shalhoub

DOI: https://doi.org/10.1093/eurheartj/ehab724.3165

IF: 39.3

2021-10-01

European Heart Journal

Abstract:Abstract Background Infective Endocarditis (IE) is a relatively uncommon but lethal condition, with no convincing evidence to date of improving mortality trends (1). The epidemiology of IE is complex, driven by a wide range of constantly evolving factors. While marked international variation has been recently reported (2), temporal trends in mortality over recent decades remain unclear. Purpose To describe trends in IE mortality in high income countries over the last 30 years. Methods Age-standardised mortality rates (ASMR) for IE, stratified by sex, were extracted from the Global Burden of Disease (GBD) database (3) between 1990 and 2019. The United Kingdom and selected countries with comparable health expenditure (EU15+ countries) were included. Relative changes in ASMR over the observation period were determined and trends were analysed using Joinpoint regression analysis. Results Between 1990–2019 ASMR from IE increased for both sexes in all included countries except Finland (−20.1% in males, −15.1% in females) and Austria (−8.98% in males, −22.6% in females). The largest increase in ASMR in males was observed in Greece (+197%), while the largest increase in females was observed in Italy (246%). Joinpoint regression analysis identified multiple significant trends within this observation period (Figure 1; clear squares indicate males, filled circles indicate females and lines represent modelled trends based on joinpoint data). At the end of the observation period the Netherlands had the highest ASMR in both males and females (2.28/100,000 in males and 2.37/100,000 in females), while Finland had the lowest ASMR in both males and females (0.45/100,000 and 0.23/100,000 respectively). Conclusions Significant international variation in IE mortality rates were observed. While mortality from IE has generally increased over the last 30 years, recent data suggest this trend may now be plateauing or even reversing in certain countries. Funding Acknowledgement Type of funding sources: None. Figure 1

cardiac & cardiovascular systems
Informed consent in psychiatry clinical research: A conceptual review of issues, challenges, and recommendations

U. Gupta,S. Kharawala

DOI: https://doi.org/10.4103/2229-3485.92301

Perspectives in Clinical Research

Abstract:Obtaining informed consent in psychiatry clinical research involving subjects with diminished mental abilities and impaired consent capacity has been a challenge for researchers, posing many ethical concerns and procedural hurdles due to participants’ cognitive deficits and impaired ability to judge reality. Regulations seem inadequate and provide limited guidance, not sufficient to address all the ethical issues inherent in different situations related to obtaining consent from decisionally impaired persons. Researchers are struggling to find a balance between risk-benefit ratio, research advancement, and autonomy of study subjects. Inspired to improve the consent process in psychiatry clinical research, many studies have been conducted focusing on various informed consent-related ethical concerns, with the aim of developing appropriate strategies and optimizing the informed consent procedure in psychiatry clinical research, overcoming the ethical concerns. This article critically reviews the various ethical issues and consent challenges, their underlying reasons, and investigates the appropriate strategies and practices needed to be adopted while obtaining informed consent from subjects with impaired consent capacity, participating in psychiatry clinical research.
Evolving trends in infective endocarditis in a developing country: a consequence of medical progress?

Mohamed Sunil,Huynh Quoc Hieu,Ramesh Singh Arjan Singh,Sasheela Ponnampalavanar,Kelvin S. W. Siew,Alexander Loch

DOI: https://doi.org/10.1186/s12941-019-0341-x

2019-12-01

Annals of Clinical Microbiology and Antimicrobials

Abstract:Abstract Background Staphylococcus has replaced streptococcus as the most common cause of infective endocarditis (IE) in developed health care systems. The trend in developing countries is less clear. Aim To examine the epidemiological trends of infective endocarditis in a developing nation. Methods Single-centre, retrospective study of patients admitted with IE to a tertiary hospital in Malaysia over a 12-year period. Results The analysis included 182 patients (n = 153 Duke’s definite IE, n = 29 possible IE). The mean age was 51 years. Rheumatic heart disease was present in 42%, while 7.6% were immunocompromised. IE affected native valves in 171 (94%) cases. Health-care associated IE (HCAIE) was recorded in 68 (37.4%). IE admission rates increased from 25/100,000 admissions (2012) to 59/100,000 admissions (2017). At least one major complication on admission was detected in 59 (32.4%) patients. Left-sided IE was more common than right-sided IE [n = 159 (87.4%) vs. n = 18 (9.9%)]. Pathogens identified by blood culture were staphylococcus group [n = 58 (40.8%)], streptococcus group [n = 51 (35.9%)] and Enterococcus species [n = 13 (9.2%)]. staphylococcus infection was highest in the HCAIE group. In-hospital death occurred in 65 (35.7%) patients. In-hospital surgery was performed for 36 (19.8%) patients. At least one complication was documented in 163 (85.7%). Conclusion Staphylococcus is the new etiologic champion, reflecting the transition of the healthcare system. Streptococcus is still an important culprit organism. The incidence rate of IE appears to be increasing. The rate of patients with underlying rheumatic heart disease is still high.

microbiology
Epidemiological profile and mortality of infective endocarditis over the past decade: a systematic review and meta-analysis of 133 studies comprising 132,355 cases

M Sagris,A T Tzoumas,D X Xenos,A N Ntoumaziou,F K Kakargias,W L Liaquat,R P Patel,S N Nagraj,D K Kokkinidis,K T Tsioufis,D T Tousoulis,L P Palaiodimos

DOI: https://doi.org/10.1093/eurheartj/ehae666.1959

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Background Understanding the epidemiology of infective endocarditis (IE) is crucial in the context of an aging population, increased comorbidities, and the heightened occurrence of healthcare-associated cases. Comprehensive data on causative agents, affected valves, and associated mortality are essential for current clinical practice. Methods This systematic review was conducted according to the PRISMA guidelines. A random effects model meta-analysis was conducted. Eligible studies reporting outcomes on IE were identified through a search of the PubMed/Medline database from 2010 to 2021. Results One hundred-thirty-three studies with 132,584 patients from six continents were included in the analysis. The most common causative agents of IE were Staphylococci species in 36% of cases, followed by Streptococci species in 26% of cases and Enterococci species in 10% of cases. Of the studies providing further speciation, the predominant species was Staphylococcus aureus with an incidence of 29%, followed by Viridans Streptococcus with an incidence of 12%. We found an in-hospital/30-day mortality of 17% (CI: 16%-19%) from 109 studies worldwide. In the subgroup analysis, the highest mortality rates were observed in Latin America 33% (CI: 28%-38%) and Africa 25% (CI: 21%-30%), while the lowest mortality rates were reported in Oceania 13% (CI: 8%-19%), followed by North America 14% (CI: 11%-18%), Asia 15% (CI: 12%-18%), and Europe 17% (CI: 16%-19%). The aortic valve was affected in 46% of cases, followed by the mitral valve in 43%. Tricuspid valve IE and multivalvular IE were identified in 7% and 14% of the cases, respectively. Conclusion Our study highlights the shift in epidemiological profile of IE over the last decade with S. aureus identified as the most common causative microorganism of IE in almost one third of cases. IE remains a highly morbid and fatal condition with high mortality rates even in tertiary and high-expertise centers worldwide. While left-sided IE is by far more common, right-sided IE and multivalvular IE are not rare entities and should be considered early in the differential of patients presenting with suspected IE to decrease the risk of future complications.Global burden of infective endocarditis.

cardiac & cardiovascular systems
[Hypothyroidism of sows and piglets after the feeding of silage from potato and rapeseed meal].

F. Schöne,G. Jahreis,H. Lüdke,B. Groppel,E. Kirchner,H. Bock

1986-07-01

Abstract:
Guidelines for the Prevention, Diagnosis, and Treatment of Infective Endocarditis in Adults: the Task Force for the Prevention, Diagnosis, and Treatment of Infective Endocarditis in Adults of Chinese Society of Cardiology of Chinese Medical Association, and of the Editorial Board of Chinese Journal of Cardiology

Y. Dong,J. Huang,G. Li,L. Li,W. Li,X. Li,X. Liu,Z. Liu,Y. Lu,A. Ma,H. Sun,H. Wang,X. Wen,D. Xu,J. Yang,J. Zhang,H. Zhao,J. Zhou,L. Zhu,Committee Members:,L. Bai,K. Cao,M. Chen,G. Dai,W. Ding,W. Dong,Q. Fang,W. Fang,X. Fu,W. Gao,R. Gao,J. Ge,Z. Ge,F. Gu,Y. Guo,H. Han,D. Hu,W. Huang,L. Huang,C. Huang,D. Huang,Y. Huo,W. Jin,Y. Ke,H. Lei,Y. Li,D. Li,Z. Li,Y. Liang,Y. Liao,G. Liu,C. Ma,D. Ma,Y. Ma,L. Shen,J. Sun,C. Sun,Y. Sun,Q. Tang,Z. Wan,J. Wang,S. Wang,D. Wang,G. Wang,Y. Wu,P. Wu,S. Wu,X. Wu,Z. Wu,T. Yang,X. Yang,Y. Yang,Z. Yang,P. Ye,B. Yu,F. Yuan,S. Zhang,Y. Zhang,R. Zhang,S. Zhao,X. Zhou

DOI: https://doi.org/10.1093/eurheartj/suv031

2015-01-01

European Heart Journal Supplements

Abstract:The pathogenesis of infective endocarditis (IE) is a complex process which can include tissue damage to the valves during bacteraemia, pathogen adherence leading to the formation of non-bacterial thrombotic vegetations, platelet aggregation at sites of tissue damage, and a variety of biological interactions between pathogens and host matrix molecules (e.g. platelets).1,2 In the past few decades, the incidence of IE has increased significantly, which may be the result of an aging population, delayed diagnosis of valvular heart disease, and even new methods of valve implantation, including transcatheter therapies. The incidence of IE of the right heart has also increased due to the prevalence of intravenous drug use. Overall, the epidemiological profile of IE in China remains inadequately characterized, and the precise epidemiology differs between geographic location and study populations. For example, in Europe, the incidence of IE is reported to be 3–10 episodes/100 000 person-years and increases with age—the peak incidence being 14.5 episodes/100 000 person-years in patients between 70 and 80 years of age, with a male : female ratio of ≥2 : 1. Over the course of the 20th century, due to effective antibiotic treatment, the major cause of IE has changed from rheumatic valve disease, which mainly affects young adults, to a variety of other aetiologies. In many locations, the most common pathogen of IE has changed from Streptococcus to Staphylococcus . In the USA, staphylococcal infection has become the most prevalent, and, in China, case reports show that Streptococcus and Staphylococcus are the most common pathogens.3–6 Despite advances in its management, IE is still considered a severe disease with a high mortality rate and poor prognosis. This consensus is …
Changing spectrum of infective endocarditis in India: An 11-year experience from an academic hospital in North India

Navneet Arora,Prashant Kumar Panda,Pruthvi Cr,Lipi Uppal,Atul Saroch,Archana Angrup,Navneet Sharma,Yash Paul Sharma,Rajesh Vijayvergiya,Manoj Kumar Rohit,Ankur Gupta,Bhupinder Kumar Sihag,Himanshu Gupta,Neelam Dahiya,Ajay Bahl,Parminder Singh,Saurabh Mehrotra,Parag Barwad,Ashok Kumar Pannu,Pruthvi CR

DOI: https://doi.org/10.1016/j.ihj.2021.09.008

2021-11-01

Indian Heart Journal

Abstract:Several studies have demonstrated a shift in the spectrum of infective endocarditis (IE) in the developed world. We aimed to investigate whether demographic and microbiologic characteristics of IE have changed in India.A retrospective analysis of patients with in north India between 2010 to 2020.The clinical and laboratory profiles of 199 IE admitted to an academic hospital patients who met the modified Duke criteria for definite IE were analysed.The mean age was 34 years, and 84% were males. The main predisposing conditions were injection drug use (IDU) (n=71, 35.7%), congenital heart disease (n=46, 21.6%), rheumatic heart disease (n=25, 12.5%), and prosthetic device (n=19, 9.5%). 17.1% of patients developed IE without identified predispositions. Among 64.3% culturepositive cases, the most prevalent causative pathogens were Staphylococcus aureus(46.1%), viridans streptococci (7.0%), enterococci (6.0%), coagulase-negative staphylococci (5.5%), gram negative bacilli (5.5%), polymicrobial (5.5%), and Candida (1.0%). The tricuspid (30.3%), mitral (25.6%), and aortic (21.6%) valves were the most common sites of infection, and 60.3% had large vegetations (>10 mm). Systemic embolization occurred in 55.3% of patients at presentation. Cardiac surgery was required for 13.1%. In-hospital mortality was 17.1% and was associated with prosthetic devices (p-value, 0.001), baseline leucocytosis (p-value, 0.036) or acute kidney injury (p-value, 0.001), and a microbial etiology of gram negative bacilli or enterococci (p-value, 0.005).IDU is now the most important predisposition for IE in India, and S. aureus has become the leading cause of native valve endocarditis with or without IDU.
Risperidone in the management of disruptive behavior disorders.

G. Pandina,M. Aman,R. Findling

DOI: https://doi.org/10.1089/CAP.2006.16.379

2006-09-07

Journal of Child and Adolescent Psychopharmacology

Abstract:Disruptive behavior disorders (DBDs) represent a spectrum of disorders, including conduct disorder and oppositional-defiant disorder. The atypical antipsychotic risperidone may be useful for the management of patients with DBDs. Clinical data on risperidone have demonstrated efficacy and satisfactory tolerability in improving angry, aggressive, self-injurious, and disruptive symptoms and behavior in children with pervasive developmental disorders and mood disorders. This paper reviews the results of recent studies that have evaluated the efficacy and safety of risperidone in the treatment of pediatric patients with DBDs. Because concerns have been raised regarding the safety of atypical antipsychotic treatment in pediatric patients, this paper further evaluates safety risks by presenting newly completed analyses of movement disorders, prolactin concentrations, body weight, and cognitive function data from short- and long-term studies in this patient population. A comprehensive review of all of the findings suggests that risperidone is an effective and well-tolerated treatment option for children and adolescents with DBDs. As with all antipsychotics, practitioners should monitor young patients' growth, weight, sexual maturation, and metabolic parameters.

Tumor vaccination after allogeneic bone marrow cell reconstitution of the non-myeloablatively conditioned tumor-bearing murine host

Global, regional, and national burden and quality of care index of endocarditis: the global burden of disease study 1990-2019

Epidemiology, burden, and attributable risks of infective endocarditis in Iran and its provinces: From 1990 to 2019

Steroid hormone regulation of the voltage‐gated, calcium‐activated potassium channel expression in developing muscular and neural systems

Characteristics of Infective Endocarditis in a Tertiary Hospital in East China

Trends in the incidence and mortality of infective endocarditis in high-income countries between 1990 and 2019

A clinical analysis of 51 cases of infective endocarditis

Mortality patterns in older adults with infective endocarditis in the US: A retrospective analysis

Clinical and Microbiological Characteristics of Infective Endocarditis at a Cardiac Center in Saudi Arabia

Infective endocarditis:a review of 28 cases

Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature

Mortality and disability-adjusted life years in North Africa and Middle East attributed to kidney dysfunction: a systematic analysis for the Global Burden of Disease Study 2019

Trends in infective endocarditis mortality in the United Kingdom and EU 15+ countries between 1990–2019: an analysis of the Global Burden of Diseases database

Informed consent in psychiatry clinical research: A conceptual review of issues, challenges, and recommendations

Evolving trends in infective endocarditis in a developing country: a consequence of medical progress?

Epidemiological profile and mortality of infective endocarditis over the past decade: a systematic review and meta-analysis of 133 studies comprising 132,355 cases

[Hypothyroidism of sows and piglets after the feeding of silage from potato and rapeseed meal].

Changing spectrum of infective endocarditis in India: An 11-year experience from an academic hospital in North India

Risperidone in the management of disruptive behavior disorders.